|
|
Volumn 162, Issue 1, 2002, Pages 201-210
|
|
A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus
a
|
|
Author keywords
Cholesterol; Fibrate; Gemfibrozil; Hydroxy methylglutaryl CoA reductase inhibitor; Lipoprotein particles; Pravastatin; Triglycerides
|
|
Indexed keywords
APOLIPOPROTEIN A1;
APOLIPOPROTEIN B;
APOLIPOPROTEIN C;
CHOLESTEROL;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PRAVASTATIN;
TRIACYLGLYCEROL;
ADULT;
ARTICLE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
DYSLIPOPROTEINEMIA;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEART PROTECTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
LIPID ANALYSIS;
LIPID COMPOSITION;
LIPOPROTEIN BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
METABOLIC DISORDER;
MONOTHERAPY;
MULTICENTER STUDY;
MUSCULOSKELETAL DISEASE;
NEUROPATHY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
SKIN DISEASE;
TREATMENT OUTCOME;
TRIACYLGLYCEROL BLOOD LEVEL;
UROGENITAL TRACT DISEASE;
AGED;
ANTILIPEMIC AGENTS;
APOLIPOPROTEINS;
CHOLESTEROL, LDL;
CHOLESTEROL, VLDL;
DIABETES MELLITUS, TYPE 2;
DOUBLE-BLIND METHOD;
DRUG EVALUATION;
FEMALE;
FOLLOW-UP STUDIES;
GEMFIBROZIL;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPOPROTEINEMIAS;
LIPOPROTEINS;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PHENOTYPE;
PRAVASTATIN;
TREATMENT OUTCOME;
TRIGLYCERIDES;
|
|
EID: 0036223852
PISSN: 00219150
EISSN: None
Source Type: Journal
DOI: 10.1016/S0021-9150(01)00700-6 Document Type: Article |
|
Times cited : (22)
|
|
References (30)
|
